
ASND, GDS, ADSK and CDZI among after hours movers
17.75BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
DK0060615755
CUSIP
04351P101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
20.88
PEG Ratio
-
Book Value
25.41
Dividend Share
-
Dividend Yield
-
Earnings Share
12.96
Wall Street Target Price
314.66
EPS Estimate Current Year
11.29
EPS Estimate Next Year
8.05
EPS Estimate Current Quarter
0.7667
EPS Estimate Next Quarter
1.3167
Most Recent Quarter
-
Revenue TTM
1,047,020,032
Gross Profit TTM
955,894,976
EBITDA
263,454,000
Profit Margin
70.85%
Return On Assets TTM
9.58%
Return On Equity TTM
118.78%
Revenue Per Share TTM
16.889
Qtly Revenue Growth YOY
114.70%
Diluted Eps TTM
12.96
Qtly Earnings Growth YOY
0.00%
Trailing PE
20.88
Forward PE
24
Price Sales TTM
16.9498
Price Book MRQ
10.6797
Enterprise Value Revenue
14
Enterprise Value EBITDA
78
126.79
5.27%154.24
3.51%211.01
0.18%1014.25
0.00%122.35
-4.84%1045.80
-0.71%31.56
-0.44%842.48
-0.14%557.47
-0.13%248.40
-0.08%